{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Fennern EB"],"funding":["NIDDK NIH HHS"],"pagination":["5531-5537"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8910464"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["35(10)"],"pubmed_abstract":["<h4>Introduction</h4>Venous thromboembolism (VTE) is a significant cause of morbidity and mortality after bariatric surgery. Roughly 80% of VTEs occur post-discharge. The frequency of post-discharge heparin (PDH) prophylaxis use is unknown, and evidence about benefits and risks is limited. We aimed to determine the rate of use of PDH prophylaxis and evaluate its relationship with VTE and bleeding events.<h4>Methods</h4>Using the Truven Health MarketScan® database, we performed a retrospective cohort study (2007-2015) of adult patients who underwent sleeve gastrectomy or gastric bypass. We determined PDH prophylaxis from outpatient pharmacy claims, and post-discharge 90-day VTE and bleeding events from outpatient and inpatient claims. We used propensity score-adjusted regression models to m"],"journal":["Surgical endoscopy"],"pubmed_title":["Use of post-discharge heparin prophylaxis and the risk of venous thromboembolism and bleeding following bariatric surgery."],"pmcid":["PMC8910464"],"funding_grant_id":["T32 DK070555"],"pubmed_authors":["Khandelwal S","Wolff EM","Farjah F","Chen JY","Verdial FC","Fennern EB","Cook SB"],"additional_accession":[]},"is_claimable":false,"name":"Use of post-discharge heparin prophylaxis and the risk of venous thromboembolism and bleeding following bariatric surgery.","description":"<h4>Introduction</h4>Venous thromboembolism (VTE) is a significant cause of morbidity and mortality after bariatric surgery. Roughly 80% of VTEs occur post-discharge. The frequency of post-discharge heparin (PDH) prophylaxis use is unknown, and evidence about benefits and risks is limited. We aimed to determine the rate of use of PDH prophylaxis and evaluate its relationship with VTE and bleeding events.<h4>Methods</h4>Using the Truven Health MarketScan® database, we performed a retrospective cohort study (2007-2015) of adult patients who underwent sleeve gastrectomy or gastric bypass. We determined PDH prophylaxis from outpatient pharmacy claims, and post-discharge 90-day VTE and bleeding events from outpatient and inpatient claims. We used propensity score-adjusted regression models to m","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Oct","modification":"2025-04-04T21:32:11.944Z","creation":"2025-04-04T21:32:11.944Z"},"accession":"S-EPMC8910464","cross_references":{"pubmed":["33025253"],"doi":["10.1007/s00464-020-08049-7"]}}